In the case of AC, a 66-year-old male admitted with diarrhea and dehydration following chemotherapy for Stage 2 colon cancer, several criteria related to his primary diagnosis and potential interventions that could delay discharge need to be considered

QUESTION

AC 66 year old male Adm. Dx: Colon cancer (Stage 2) – received chemotherapy last week in the outpatient cancer center. Hosp. day 2, admitted for diarrhea and dehydration PMH: Colon resection 2 months ago Soc. Hx: Married, lives with wife and 3 children (20 yrs, 18 yrs and 12 yrs); Wt: 62.7 kg; Employed, owns home, health insurance, occasional alcohol intake, non-smoker Report: Port-a-cath CVC in place – site clean/dry FOLFOX protocol (5-FU, leucovorin and oxaliplatin) last week Bland diet, unable to tolerate Antiemetics and anti-diarrheals PRN D5 ½ NS w/20 mEq KCL @ 100 mL/hr Morning labs: RBCs – 3.8, Hgb 12, Hct 38, WBCs 4, Platelets 99 Stool culture negative for C-diff

1. Identify at least 3 criteria related to primary diagnosis and interventions that could delay discharge.

a. Include evidence-based strategies utilized to prevent these complications (with references)

ANSWER

In the case of AC, a 66-year-old male admitted with diarrhea and dehydration following chemotherapy for Stage 2 colon cancer, several criteria related to his primary diagnosis and potential interventions that could delay discharge need to be considered. These criteria and interventions are crucial for ensuring optimal patient outcomes and preventing complications.

Diarrhea and Dehydration

Diarrhea and dehydration are common complications following chemotherapy, and they can significantly impact patient recovery and well-being. AC’s recent chemotherapy treatment (FOLFOX protocol) and his history of colon resection put him at a higher risk for these complications.

Interventions to prevent complications

Fluid and Electrolyte Management: AC’s RBC, Hgb, Hct, and Platelet levels are within acceptable ranges, but his WBC count is slightly low, indicating a potential risk of infection. Monitoring his fluid intake, electrolyte balance, and vital signs closely is essential to prevent dehydration and electrolyte imbalances. The current intravenous fluid regimen (D5 ½ NS w/20 mEq KCL @ 100 mL/hr) should be continued, and his fluid balance needs to be monitored regularly.

Nutritional Support: AC’s bland diet is an appropriate approach to manage diarrhea; however, ensuring proper nutritional intake is vital for his recovery. Consultation with a registered dietitian to tailor his diet to his specific needs, including a balance of fluids, electrolytes, and nutrients, is crucial.

Medication Management: The use of antiemetics and anti-diarrheals as needed (PRN) is essential to control symptoms and prevent further dehydration. However, a comprehensive assessment of his response to these medications is necessary to determine their effectiveness and adjust the dosages accordingly.

Infection Prevention: Despite the negative C-diff stool culture, the risk of infection is still present due to his compromised immune system from chemotherapy. Implementation of infection prevention measures, including good hand hygiene and isolation precautions, is crucial to minimize the risk of infection.

Patient Education: AC and his family should receive education on the signs and symptoms of dehydration, infection, and other potential complications. This knowledge empowers them to recognize problems early and seek medical attention promptly.

Evidence-based strategies and references

For fluid and electrolyte management, guidelines from the American Society of Clinical Oncology (ASCO) recommend close monitoring of electrolyte levels and the use of intravenous fluids based on the patient’s clinical status[^1].
The Oncology Nursing Society (ONS) provides evidence-based guidelines for managing chemotherapy-related diarrhea, including dietary modifications and pharmacologic interventions[^2].
The Centers for Disease Control and Prevention (CDC) offers guidelines on infection prevention in healthcare settings, including strategies to reduce the risk of healthcare-associated infections[^3].
The American Cancer Society (ACS) provides patient education materials on managing side effects of chemotherapy, including diarrhea and dehydration[^4].

In conclusion, AC’s risk of complications such as diarrhea and dehydration following chemotherapy necessitates a comprehensive approach to care. By employing evidence-based strategies and closely monitoring his fluid status, electrolyte balance, and overall well-being, the healthcare team can prevent potential complications, optimize his recovery, and ensure a safe discharge.